4.7 Article

A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets

期刊

BLOOD
卷 141, 期 18, 页码 2214-2223

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood.2022018825

关键词

-

向作者/读者索取更多资源

Clonal hematopoiesis of indeterminate potential (CHIP) is a common age-related somatic mosaicism associated with significant morbidity and mortality. Differentiating true CHIP mutations from sequencing artifacts and germ line variants is a bioinformatic challenge. We present a stepwise method to improve the accuracy of CHIP calls using filtering, variant annotation, and population-based associations. This high-fidelity call set refines population-based associations of CHIP with incident outcomes and is crucial for clinical diagnostic assays.
Clonal hematopoiesis of indeterminate potential (CHIP) is a common form of age-related somatic mosaicism that is associated with significant morbidity and mortality. CHIP mutations can be identified in peripheral blood samples that are sequenced using approaches that cover the whole genome, the whole exome, or targeted genetic regions; however, differentiating true CHIP mutations from sequencing artifacts and germ line variants is a considerable bioinformatic challenge. We present a stepwise method that combines filtering based on sequencing metrics, variant annotation, and population-based associations to increase the accuracy of CHIP calls. We apply this approach to ascertain CHIP in similar to 550 000 individuals in the UK Biobank complete whole exome cohort and the All of Us Research Program initial whole genome release cohort. CHIP ascertainment on this scale unmasks recurrent artifactual variants and highlights the importance of specialized filtering approaches for several genes, including TET2 and ASXL1. We show how small changes in filtering parameters can considerably increase CHIP misclassification and reduce the effect size of epidemiological associations. Our high-fidelity call set refines previous population-based associations of CHIP with incident outcomes. For example, the annualized incidence of myeloid malignancy in individuals with small CHIP clones is 0.03% per year, which increases to 0.5% per year among individuals with very large CHIP clones. We also find a significantly lower prevalence of CHIP in individuals of self-reported Latino or Hispanic ethnicity in All of Us, highlighting the importance of including diverse populations. The standardization of CHIP calling will increase the fidelity of CHIP epidemiological work and is required for clinical CHIP diagnostic assays.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据